Font Size: a A A

The potential role of VH replacement in editing and generating autoreactive antibodies

Posted on:2010-08-27Degree:Ph.DType:Dissertation
University:The University of Alabama at BirminghamCandidate:Fan, RunFull Text:PDF
GTID:1444390002480259Subject:Microbiology
Abstract/Summary:
VH replacement occurs through RAG-mediated secondary recombination between an upstream VH gene and an existing VHDJ H joint. In the first part of this dissertation, we focused on the potential regulation of VH replacement in the human B lineage EU12 cells muHC + population, which underwent spontaneous VH replacement during in vitro culture. We cloned one of the dominant IgH genes, A19H, expressed in the EU12 muHC+ cells, and generated recombinant antibodies. We found that these recombinant antibodies recognize SM antigens. The anti-SM reactivity of A19H can not be efficiently neutralized by a randomly selected group of fourteen IgL chains from healthy controls, suggesting that the SM reactivity is mainly contributed by the A19H heavy chain. Indeed, the anti-SM reactivity was attenuated in the subsequent V H replacement product, A21H, cloned from the EU12 muHC+ cells. These results indicated that VH replacement is essential to edit IgH genes encoding anti-SM antibodies.;In the second part of this dissertation, we investigated the potential contribution of VH replacement in systematic lupus erythematosus (SLE). We performed single cell PCR assay and cloned 447 IgH genes with paired Igkappa or Iglambda genes from plasma cells (CD19lowCD27 high) and naive B cells (CD19+CD27-) of three SLE patients and two healthy controls. Analyses of the IgL genes from SLE patients showed signs of excessive receptor editing of IgL genes, leading to elevated usages of downstream Jkappa5 and Jlambda3 genes. Strikingly, the frequency of VH replacement products in the IgH genes from all three SLE patients is significantly higher than in the control clones, especially in plasma cells. The VH replacement 'footprints' preferentially encoded charged amino acids in the IgH CDR3 regions. Analyses of 12 recombinant antibodies derived from SLE plasma cells showed that 75% of recombinant antibodies recognize with cytoplasmic or nuclear antigens, in which more than half of them are encoded by VH replacement products.;Taken together, the works presented in this dissertation suggested that VH replacement is normally employed to delete unwanted IgH genes; however, excessive VH replacement might generate IgH genes with extremely long CDR3 regions, which encode autoreactive antibodies.;Keywords. VH replacement, EU12, autoreactive antibody, SM antigen, SLE.
Keywords/Search Tags:VH replacement, Antibodies, Three SLE patients, Igh genes, EU12 muhc, CDR3 regions, Potential
Related items
Regulation of VH replacement in human immature B cells by B cell receptor (BCR)-mediated signaling
Characteristic Analysis Of Peripheral Blood TCR ? CDR3 And TCR ? CDR3 Repertoire And Screening Of Immune-related Genes In Patients With Active And Inactive SLE
The Effect Of IL-15 On The HIV Vaccine-induced Immune Response And The Screening And Identification Of The CDR3 Of TCR Vδ1 In HIV-infected Patients And Corresponding Antigen Epitope Peptides
The Influence Of HBV Persistent Infection On The CDR3 Spectratype Of αβT Cell Receptor β Chain In The Peripheral Blood Of Patients
1.Research On The Level Of Several Autoantibodies In Serums Of SLE Patients And The Application Assessment Of Them In Laboratory Diagnosis Of SLE Patients 2. The Systematic Review Of Anti-nucleosome Antibody In Diagnosis Of SLE
A Preliminary Study On The Immune Repertoire Of Peripheral Blood IgH-CDR3 In Patients With Nmosd
Identifying Genes As Potential Prognostic Indicators In Patients With Serous Ovarian Cancer Resistant To Carboplatin Using Integrated Bioinformatics Analysis
Study On Proteins Encoded By The Regions Of Deletion Genes Of Vaccine Strain Of Bcg
T Cell Receptor Cdr3¦Ä Transplant Antibody (ot3) - Immunotoxin Anti-tumor Research And Cdr3¦Ä Peptide Conformational Studies,
10 Study On The Microbial Community Composition Of Subgingival Plaques And The Heterogeneity Of TCR? CDR3 Repertoire Of Tumor Tissue In Patients With Moderate To Severe Periodontitis With OSCC